フッ化物に対する広範囲にわたる遺伝子スイッチと毒性耐性タンパク質
Jenny L Baker1, Narasimhan Sudarsan2,3, Zasha Weinberg2,3
1Department of Chemistry, Yale University, Box 208103, New Haven, CT 06520, USA.
Science (New York, N.Y.)
|December 24, 2011
まとめ
科学者たちは,細菌と古生物の体内で,新しいフッ素リボスイッチを発見した. これらのRNA構造は,フッ素を感知し,それに反応し,生物が有毒なフッ素レベルを管理するのを助ける遺伝子を制御します.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- バイオケミストリー バイオケミストリー
背景:
- リボスイッチは,通常,細菌のメッセンジャーRNAに含まれる規制RNA要素です.
- 小分子 (代謝物質) に結合することで遺伝子発現を制御する.
- 多くのリボスイッチの機能は,特定の環境のシグナルへの反応として,ほとんど特徴づけられていないままです.
研究 の 目的:
- 新しいリボスイッチのクラスを発見し,特徴づけること.
- 環境アニオン,特にフッ素を感知するリボスイッチの役割を調査する.
- バクテリアと古生物がフッ化物曝露に対処するために使用する遺伝的および細胞メカニズムを理解するために.
主な方法:
- 保存されたRNA構造を特定するために,バクテリアおよびアーカイアゲノムのバイオ情報分析.
- 特定されたリボスイッチの結合特異性を様々なアニオンにテストするためのインビトロアッセイ.
- レポーター遺伝子アッセイは,リボスイッチがフッ素に反応して,その調節活動を測定するものです.
主要な成果:
- フッ化物イオンによって選択的に活性化されるリボスイッチの新種の発見.
- これらのフッ素リボスイッチは,様々な細菌や古代生物の種に存在しています.
- リボスイッチは,フッ素の輸送と代謝に関与する遺伝子,および未知の機能のタンパク質を調節する.
結論:
- 多くの生物は,有毒なレベルのフッ化物にさらされています.
- フッ素を感知するリボスイッチは,フッ素への反応として遺伝子発現を制御するための広範なメカニズムです.
- これらのRNAベースのセンサーは,フッ素ストレスへの細胞適応において重要な役割を果たします.
関連する概念動画
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:16Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...